Search

everythinglearnresearchcommunity

for

Search:↓

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Hepatitis C virus can cause skin diseases and dermatologists play a crucial role in identifying these conditions.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

People with chronic Hepatitis C often have skin problems like itching and contact dermatitis, especially older individuals and women.

A woman with chronic hepatitis C had a rare skin condition linked to her illness.

Long-term high-dose fluconazole can cause reversible hair loss.

Patients with lichen planus should be tested for hepatitis C.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

A woman with asthma improved from a severe fungal infection after treatment change, and most HIV-positive women in a UK study had low immune cell counts but were responding well to treatment.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The meeting highlighted major advances in skin research, including new findings on skin microbes, genetic links to skin diseases, and improved treatments for various conditions.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

A woman was diagnosed with porphyria cutanea tarda and improved with phlebotomy and lifestyle changes.

Many women with HIV in the North of England are diagnosed late and have other health conditions.

Minoxidil is better for female hair loss without hormonal issues, cyproterone acetate for those with; people with treated congenital heart disease have lower life quality; personality differs in types of infertility; oral terbinafine is best for toenail fungus; bladder training reduces incontinence; nurse clinics help with heart disease; weight loss improves body composition and liver disease; computer training cuts drug errors.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Most patients with Porphyria Cutanea Tarda had skin blisters and were often affected by hepatitis C and alcohol abuse, with differences between familial and sporadic cases.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

A genetic marker linked to a type of hair loss was found in most patients studied.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.